Bloomage Biotechnology Corporation Limited (formerly Bloomage Freda Biopharm), established by Bloomage International Investment Group, is a national High-Tech enterprise. Since 1990s, for the first time in China, developed fermentation procedure to manufacture Sodium Hyaluronate,Bloomage Biotech has devoted its efforts on research, development, and production in biotechnology field, not only on the innovation in Sodium hyaluronate, but also on relevant bioactive ingredients. As the raw material business unit, Bloomage Biotech Bioactive will keep providing innovative solutions and technical support to our valued partners.